1 |
Laurent Poirel, Thierry Naas, Michele Guibert, et al., Molecular and Biochemical Characterization of VEB-1, a Novel Class A Extended-Spectrum -Lactamase Encoded by an Escherichia coli Integron Gene. Antimicrob. Agents Chemother. March 1999 vol. 43 no.3 573-581
|
2 |
Xavier DE, Picao RC, Girardello R, Fehlberg LC, Gales AC.Efflux pumps expression and its association with porin down-regulation and beta-lactamase production am ong Pseudomonas aeruginosa causing bloodstream infec tions in Brazil.BMC Microbiol. 2010 Aug 12;10:217.
DOI
ScienceOn
|
3 |
Ranellou K, Kadlec K, Poulou A, et al., Detection of Pseudomonas aeruginosa isolates of the international clonal complex 11 carrying the blaPER-1 extended-spectrum b-lactamase gene in Greece, J Antimicrob Chemother 2012; 67:357 361 DOI: http://dx.doi.org/10.1093/jac/dkm226
DOI
ScienceOn
|
4 |
Kim JM, Kang HK, Jeong SH et al. Prevalence of PER-1 Extended-Spectrum -Lactamase-Producing Clinical Isolates of Acinetobacter baumannii in a University Hospital, Busan, Korea: Korean J Clin Microbiol; 7(1): 20-26, 2004.
|
5 |
Lee BY, Jeong SH, Jeong TS, Nam HJ, Ji JH, Hong YR. Detection of extended-spectrum -lactamase producing Escherichia coli and Klebsiella spp. with the Vitek GNS 121 card. Korean J Clin Pathol; 21:350-4, 2001.
|
6 |
Edelstein M, Pimkin M, Palagin I, Edelstein I, and Stratchounski L :Prevalence and Molecular Epidemiology of CTX-M Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals. Antimicrob Agents Chemother, 47: 3724-3732, 2003. DOI: http://dx.doi.org/10.1128/AAC.47.12.3724-3732.2003
DOI
ScienceOn
|
7 |
Bush K (2001): New -lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial Gaussard S and Courvalin P (1999) : Updated sequence information TEM -lactamase genes. Antimicrob Agents Chemother, 43: 367-370. herapy. Clin Infect Dis, 32: 1085-1089.
DOI
ScienceOn
|
8 |
Gaussard S and Courvalin P : Updated sequence information TEM -lactamase genes. Antimicrob Agents Chemother, 43: 367-370,1999.
DOI
ScienceOn
|
9 |
Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev ;14:933-51, 2001. DOI: http://dx.doi.org/10.1128/CMR.14.4.933-951.2001
DOI
ScienceOn
|
10 |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. M100-S16. Wayne, Pensylvania: CLSI, 2006.
|
11 |
Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broadspectrum -lactamases conferring transferable resistance to newer -lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988; 10: 867-78. DOI: http://dx.doi.org/10.1093/clinids/10.4.867
DOI
|
12 |
Pai HJ. The characteristics of extended-spectrum -lactamases in Korean isolates of Enterobacteriaceae. Yonsei Med J 1998; 39: 514-9.
DOI
ScienceOn
|
13 |
Steward CD, Rasheed K, Hubert SK, Biddle JW, Raney PM, Anderson GJ, et al. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum -lactamase detection methods. J Clin Microbiol ; 39: 2864-72, 2001. DOI: http://dx.doi.org/10.1128/JCM.39.8.2864-2872.2001
DOI
ScienceOn
|
14 |
Kang JH, Bae IK, Kwon SB, Jeong SH, Lee JW, Lee WG, et al. Prevalence of Ambler Class A extended-spectrum -lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Korea. Korean J Clin Microbiol ;8:17-25, 2005.
|
15 |
Park JH, Lee SH, Jeong SH, Kim BN, Kim KB, Yoon JD, et al. Characterization and prevalence of Escherichia coli and Klebsiella pneumoniae isolates producing an extended-spectrum -lactamase from Korean hospitals. Korean J Lab Med; 23:18-24, 2003.
과학기술학회마을
|
16 |
Lee JH, Bae IK, Kwon SB, Jeong SH, Woo GJ, Lee JW, et al. Prevalence of CTX-M-type extended-spectrum -lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Korea, 2003. Korean J Clin Microbiol; 7:111-8, 2004.
|
17 |
Chi Seon Ko, Ji Yun Sung, Sun Hoe Koo, et al.,Prevalence of Extended-Spectrum -lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon: Korean J Lab Med 2007;27:344-50. DOI: http://dx.doi.org/10.3343/kjlm.2007.27.5.344
DOI
ScienceOn
|
18 |
Walther-Rasmussen, J., and N. Hoiby. Class A carbapenemases. J. Antimicrob. Chemother. 60:470-482, 2007. DOI: http://dx.doi.org/10.1093/jac/dkm226
DOI
ScienceOn
|
19 |
Shin KS and Son BR. Comparison of Vitek ESBL test and other methods for detecting extended-spectrum - lactamase producing Escherichia coli and Klebsiella Species. Korean J Clin Pathol; 22:21-6, 2002.
과학기술학회마을
|
20 |
Jones RN, Pfaller MA, Doern GV, Erwin ME, Hollis RJ. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group. Diagn Microbiol Infect Dis ;30:215-28, 1998. DOI: http://dx.doi.org/10.1016/S0732-8893(97)00234-4
DOI
ScienceOn
|
21 |
Hong SG, Kang MS, Choi JR, Lee KW, Chong YS, Kwon OH. Molecular characteristics of extended-spectrum -lactamases in clinical isolates of Enterobacteriaceae. Korean J Clin Pathol; 21:495-504, 2001.
|